161 related articles for article (PubMed ID: 9644873)
21. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration.
Marcinkiewicz M; Peura DA; Sarosiek J
Am J Gastroenterol; 1996 Feb; 91(2):360-5. PubMed ID: 8607507
[TBL] [Abstract][Full Text] [Related]
22. [Aspirin and gastroduodenal toxicity. A double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects].
Bretagne JF; Feuillu A; Gosselin M; Gastard J
Gastroenterol Clin Biol; 1984 Jan; 8(1):28-32. PubMed ID: 6698337
[TBL] [Abstract][Full Text] [Related]
23. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A
Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
Schüetz E; Sánchez J; García-Barbal J; Sarti JF; Reuter C; Harrison FJ
Eur J Rheumatol Inflamm; 1991; 11(4):21-8. PubMed ID: 1365486
[TBL] [Abstract][Full Text] [Related]
26. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
Müller P; Simon B
Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
[TBL] [Abstract][Full Text] [Related]
27. Sucralfate therapy in NSAID bleeding gastropathy.
Malagelada JR; Rodríguez de la Serna A; Dammann HG; Pons M; Armas C; Sala M; Tena X; Celdrán E; Mesa A
Clin Gastroenterol Hepatol; 2003 Jan; 1(1):51-6. PubMed ID: 15017517
[TBL] [Abstract][Full Text] [Related]
28. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
30. S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man.
Zoli G; Pasquinelli G; Bonvicini F; Gasbarrini G; Laschi R
Int J Tissue React; 1986; 8(1):47-53. PubMed ID: 3949442
[TBL] [Abstract][Full Text] [Related]
31. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
Warrington S; Debbas N; Farthing M; Horton M; Umile A
Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
[TBL] [Abstract][Full Text] [Related]
32. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
[TBL] [Abstract][Full Text] [Related]
33. [Effective prevention of piroxicam-induced lesions of the gastric mucosa with nizatidine].
Dammann HG; Simon-Schultz J; Dreyer M; Simon B; Müller P
Z Gastroenterol; 1990 Feb; 28(2):94-6. PubMed ID: 1969684
[TBL] [Abstract][Full Text] [Related]
34. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
[TBL] [Abstract][Full Text] [Related]
35. [Gastroduodenal lesions in rheumatoid arthritis. Evaluation and treatment].
Martínez RO; Casas H; Mazure PA; Leczycki H; Cosen JN; Canievsky L; Abib A
Acta Gastroenterol Latinoam; 1988; 18(2):87-96. PubMed ID: 3075109
[TBL] [Abstract][Full Text] [Related]
36. Effects of a synthetic prostanoid, rosaprostol, on the changes of gastric acidity and digestive disorders induced by NSAID.
Di Murro R; Camarri E; Ciani D; Mariotti L; Nencioni C; Romagnoli AM
Int J Clin Pharmacol Res; 1988; 8(5):345-51. PubMed ID: 3068160
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
38. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation.
Roth SH; Bennett RE; Mitchell CS; Hartman RJ
Arch Intern Med; 1987 Oct; 147(10):1798-801. PubMed ID: 3310942
[TBL] [Abstract][Full Text] [Related]
39. [Endoscopic study of digestive lesions caused by the use of nonsteroidal anti-inflammatory agents in rheumatic patients].
van Linthoudt D; Kocher F; Ott H
Schweiz Med Wochenschr; 1987 Apr; 117(16):604-8. PubMed ID: 3495881
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
